Applied Therapeutics, Inc. Operating Lease Liability
Applied Therapeutics, Inc. had Operating Lease Liability of $2.50 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-11-13
- 2025-09-30: Operating Lease, Liability $2.50M.
- 2025-06-30: Operating Lease, Liability $2.60M.
- 2025-03-31: Operating Lease, Liability $2.70M.
- 2024-12-31: Operating Lease, Liability $2.79M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-09-30 | $2.50M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.60M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.70M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.79M 10-K · filed 2025-04-15 |
| 2024-09-30 | $1.97M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $215.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $343.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $467.00K 10-K · filed 2024-03-06 |
| 2023-09-30 | $535.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $656.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $774.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $891.00K 10-K · filed 2023-03-23 |
| 2022-09-30 | $1.01M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.12M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.23M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.33M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.44M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.54M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.64M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.74M 10-K · filed 2021-03-18 |
| 2020-09-30 | $1.78M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.86M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.95M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.04M 10-K · filed 2020-03-13 |